Low-Concentration Hydrogen Inhalation Suppresses Bone Marrow Damage from Radiation Therapy: Significantly Reduces Leukopenia and Thrombocytopenia | MiZ & 5 Institutions Joint Research
NQ Score
44/100
N1 Content Completeness
5
AI Summary (NQ-processed)
MiZ Corporation and a joint research group have clinically demonstrated that low-concentration hydrogen inhalation significantly suppresses leukopenia and thrombocytopenia in cancer patients undergoing Intensity-Modulated Radiation Therapy (IMRT). This research highlights the importance of safe, low-concentration hydrogen inhalation for mitigating radiation therapy side effects.